Serina Therapeutics, Inc. (SER) (CIK 0001708599) (SER)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: Jun. 1, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 1, 2026 | CORRESP | Neutral/Informational | Moderate | Serina Therapeutics, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking to have the st… | Read Filing EDGAR |
| May. 29, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Serina Therapeutics, Inc. that it will not review the company's registration statement filed on May 22, 2026. This indicates that the responsibility fo… | Read Filing EDGAR |
| Feb. 11, 2026 | CORRESP | Neutral/Informational | Moderate | Serina Therapeutics, Inc. has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking for the statem… | Read Filing EDGAR |
| Feb. 9, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has notified Serina Therapeutics, Inc. that it will not review their registration statement filed on January 30, 2026. This correspondence emphasizes the company's respons… | Read Filing EDGAR |